NCT06691412: Obeticholic Acid Among Chronic HBV Patients with Hepatic Steatosis : Clinical and Portal Doppler Outcomes
- State
- Not started
- Phase
- Phase 3
- People
- 100 planned
- Started
- 15 Nov 2024
- Primary completion
- 1 Jan 2026
- Arms
- the group will receive obeticholic acid
- Results
- None posted
- 15 Nov 2024: Trial registered